Evidence map›Paper›PMID 32552278›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Patient-Level Factors Associated With Lack of Health Care Provider Recommendation for the Human Papillomavirus Vaccine Among Young Cancer Survivors.

Jocelyn M York, James L Klosky, Yanjun Chen, James A Connelly, Karen Wasilewski-Masker, Anna R Giuliano, Leslie L Robison, F Lennie Wong, Melissa M Hudson, Smita Bhatia and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Vaccination of Adults With Cancer: ASCO Guideline.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Guideline
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Jocelyn M YorkUniversity of Alabama at Birmingham, Birmingham, AL.
James L KloskyEmory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA.
Yanjun ChenUniversity of Alabama at Birmingham, Birmingham, AL.
James A ConnellyVanderbilt University, Nashville, TN.
Karen Wasilewski-MaskerEmory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA.
Anna R GiulianoCenter for Immunization and Infection Research in Cancer, H. Lee Moffitt Cancer Center, Tampa, FL.
Leslie L RobisonSt Jude Children's Research Hospital, Memphis, TN.
F Lennie WongCity of Hope, Duarte, CA.
Melissa M HudsonSt Jude Children's Research Hospital, Memphis, TN.
Smita BhatiaUniversity of Alabama at Birmingham, Birmingham, AL.
Wendy LandierUniversity of Alabama at Birmingham, Birmingham, AL.
University of Alabama at Birmingham · USSt. Jude Children's Research Hospital · USChildren's Healthcare of Atlanta · USCity of Hope · USEmory University · USMoffitt Cancer Center · USVanderbilt University · US

Funding

Quadrivalent Human Papillomavirus (HPV) Vaccine in Cancer SurvivorsR01CA166559 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KLOSKY, JAMES, LANDIER, WENDY · 2012 to 2016
$3.0M
NCI NIH HHS R01 CA166559
6 · The paper itself

Abstract

purposeYoung cancer survivors are at increased risk for morbidities related to infection with the human papillomavirus (HPV), yet their HPV vaccine initiation rates remain low. Patient-/parent-reported lack of health care provider recommendation for HPV vaccination is strongly associated with vaccine noninitiation. We aimed to identify patient-level factors associated with survivor-/parent-reported lack of provider recommendation for HPV vaccination among young cancer survivors.

methodsCancer survivors ages 9-26 years and 1-5 years off therapy completed a cross-sectional survey (parent-completed for survivors 9-17 years of age). Lack of health care provider HPV vaccine recommendation was the outcome of interest in a multivariable logistic regression model that included relevant patient-level sociodemographic, clinical, and vaccine-related variables.

resultsOf 955 survivors, 54% were male, 66% were non-Hispanic White, and 36% had leukemia. At survey participation, survivors were an average age (± standard deviation) of 16.3 ± 4.7 years and 32.8 ± 14.7 months off therapy. Lack of provider HPV vaccine recommendation was reported by 73% (95% CI, 70% to 75%) of survivors. For the entire cohort, patient-level factors associated with lack of reported provider recommendation included perceived lack of insurance coverage for the HPV vaccine (odds ratio [OR], 4.0; 95% CI, 2.7 to 5.9;

conclusionWe identified factors characterizing survivors at risk for not reporting receipt of a health care provider HPV vaccine recommendation. Future research is needed to develop interventions that facilitate effective provider recommendations for HPV vaccination among all young cancer survivors.

Indexed as

AdolescentAdultCancer SurvivorsChildCommunicationCross-Sectional StudiesFemaleHealth PersonnelHumansImmunization ProgramsInsurance CoverageMalePapillomavirus InfectionsPapillomavirus VaccinesSex FactorsSurveys and QuestionnairesPapillomavirus Vaccines

Identifiers

PMID32552278
PMCPMC7460153
OpenAlexW3035976854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.